LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
Ying Zeng(Central South University), Yuan‐Shan Zhu(Cornell University), Haibo Zhang(Wuhan University), Chengfang Zhou(Army Medical University), Wei Zhang(Central South University), Hong‐Hao Zhou(Central South University), Hong Sun(Fujian Provincial Hospital), Guo Wang(Central South University), Rong Liu(Central South University)
Cited by 26
Related Papers
LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
|Cell Death and Disease|2021|117
Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening
|Cell stem cell|2024|95
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
|Scientific Reports|2017|89
Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cells
|Cell & Bioscience|2018|84